|
Market Closed -
Nasdaq
01:30:00 20/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 22.01 USD | +4.41% |
|
-7.95% | -68.35% |
| 30/09 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 21/09 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| Market Cap | 156.95Cr 139.91Cr 129.6Cr 117.84Cr 221.12Cr 15TCr 224.76Cr 1.55TCr 611.27Cr 7.78TCr 588.87Cr 576.55Cr 25TCr | P/E 2026 * |
-13.6x | P/E 2027 * | -10.1x |
|---|---|---|---|---|---|
| Enterprise Value | 60Cr 54Cr 50Cr 45Cr 85Cr 5.71TCr 86Cr 596.6Cr 234.6Cr 2.98TCr 226.01Cr 221.28Cr 9.54TCr | EV / Sales 2026 * |
14.5x | EV / Sales 2027 * | 22,229x |
| Free-Float |
94.05% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GPCR | Delayed | |
CBOE
| GPCR | Real-time |
Last Transcript: Structure Therapeutics Inc.
| 1 day | +4.41% | ||
| 1 week | -7.95% | ||
| Current month | -29.61% | ||
| 1 month | -37.11% | ||
| 3 months | -54.60% | ||
| 6 months | -56.63% | ||
| Current year | -68.35% |
| 1 week | 20.72 |  | 22.89 |
| 1 month | 20.72 | | 37.74 |
| Current year | 20.72 | | 94.77 |
| 1 year | 20.72 | | 94.9 |
| 3 years | 13.22 | | 94.9 |
| 5 years | 13.22 | | 94.9 |
| 10 years | 13.22 | | 94.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jun Yoon
DFI | Director of Finance/CFO | 48 | 01/05/2022 |
Raymond Stevens
CEO | Chief Executive Officer | 62 | 01/05/2019 |
Matthew Lang
COO | Chief Operating Officer | 49 | 15/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Raymond Stevens
BRD | Director/Board Member | 62 | 01/02/2019 |
Daniel Welch
CHM | Chairman | 68 | 19/01/2022 |
Sharon Tetlow
BRD | Director/Board Member | 66 | 29/03/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/09/26 | Conversion | Chief Technology Officer | -20,040 | 0.0143% | ||
| 01/09/26 | Exercice | Chief Technology Officer | 65,329 | 0.0467% | ||
| 18/08/26 | Exercice | Chief Technology Officer | 43,329 | 0.0310% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.41% | -7.95% | -19.61% | -67.13% | 150.32Cr | |
| +1.52% | -7.19% | +51.66% | +69.99% | 6.5TCr | |
| +1.52% | +6.83% | +10.77% | +79.30% | 5.12TCr | |
| +0.30% | -0.46% | +2.53% | +61.89% | 5.12TCr | |
| -0.38% | +1.40% | +29.98% | +42.37% | 4.39TCr | |
| +0.30% | +5.64% | +16.99% | +133.30% | 4.2TCr | |
| +2.35% | -6.08% | +236.69% | +528.10% | 3.81TCr | |
| +2.16% | +9.87% | +18.92% | +59.70% | 3.32TCr | |
| -0.90% | -8.45% | +37.09% | +4.90% | 2.52TCr | |
| +1.60% | +2.21% | +21.34% | +28.00% | 2.25TCr | |
| Average | +1.29% | -1.78% | +40.63% | +94.04% | 3.74TCr | |
| Weighted average by Cap. | +0.99% | -0.23% | +45.77% | +112.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.17Cr 3.71Cr 3.44Cr 3.13Cr 5.87Cr 395.04Cr 5.97Cr 41Cr 16Cr 206.47Cr 16Cr 15Cr 660.03Cr | 45.45T 40.51T 37.53T 34.12T 64.03T 43.09L 65.08T 5L 2L 22.52L 2L 2L 72L |
| Net income | -31Cr -28Cr -26Cr -24Cr -44Cr -2.98TCr -45Cr -310.8Cr -122.21Cr -1.55TCr -117.74Cr -115.27Cr -4.97TCr | -47Cr -42Cr -39Cr -35Cr -66Cr -4.47TCr -67Cr -466.52Cr -183.45Cr -2.33TCr -176.73Cr -173.03Cr -7.46TCr |
| Net Debt | -97Cr -86Cr -80Cr -73Cr -136.26Cr -9.17TCr -138.5Cr -957.89Cr -376.67Cr -4.79TCr -362.87Cr -355.27Cr -15TCr | -56Cr -50Cr -46Cr -42Cr -79Cr -5.3TCr -80Cr -553.84Cr -217.79Cr -2.77TCr -209.81Cr -205.42Cr -8.86TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/26/19 | $22.01 | +4.41% | 13,12,607 |
| 16/26/16 | $21.08 | -5.00% | 11,60,791 |
| 15/26/15 | $22.19 | +1.42% | 14,14,161 |
| 14/26/14 | $21.88 | -1.93% | 20,69,294 |
| 13/26/13 | $22.31 | -6.69% | 14,44,742 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GPCR Stock
Select your edition
All financial news and data tailored to specific country editions
